| Professional Services Industry | Industrials Sector | Mr. Hongjun Liang CEO | XSHE Exchange | CNE100001Y26 ISIN |
| CN Country | 1,098 Employees | 29 May 2026 Last Dividend | 3 May 2016 Last Split | - IPO Date |
Beijing Strong Biotechnologies, Inc. is a prominent entity in the biotechnology industry, principally focusing on the development, production, and distribution of in-vitro diagnostics products and services both within the People's Republic of China and on an international scale. Founded in 2001, the company has cemented its position in the healthcare sector, showcasing a comprehensive portfolio of diagnostics solutions aimed at enhancing clinical biochemistry, coagulation, pathology, and serology testing. Headquartered in Beijing, the company's extensive range of products, coupled with its innovative technologies, significantly contributes to the advancement of medical diagnostics and patient care, reflecting its commitment to quality and excellence in the healthcare industry.
These offerings include a variety of reagents and state-of-the-art automatic biochemistry analyzers designed for efficient and accurate analysis of biological fluids. These products are crucial in diagnostics and regular health screenings, facilitating the detection of a myriad of conditions by analyzing chemical substances in blood and other body fluids.
Comprising both reagents and automated coagulation analyzers, these products play an essential role in the assessment of blood clotting mechanisms. They are vital for diagnosing disorders related to bleeding and clotting, which can have significant implications in surgery, hematology, and other medical fields.
This category includes advanced technologies and methodologies for the analysis of biological tissues and fluids, especially for cancer diagnostics. Liquid biopsy products, in particular, represent a cutting-edge approach in oncology, allowing for the detection and monitoring of cancer through the analysis of non-solid biological tissues.
Encompassing blood type test cards and automated blood grouping analyzers, these products are fundamental in determining an individual's blood type. This is crucial for blood transfusions, organ transplants, and in understanding the immune response, thus playing a vital role in both emergency and routine medical care.
In addition to these innovatively designed products, Beijing Strong Biotechnologies, Inc. extends its expertise to the rental of healthcare instruments, thereby ensuring even broader access to its advanced technologies. Furthermore, the company offers comprehensive inspection services, underscoring its commitment to supporting healthcare providers in delivering accurate and efficient diagnostic services.